Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 1
1967 1
1970 2
1972 1
1973 2
1976 3
1984 4
1986 3
1987 7
1988 10
1989 4
1990 5
1991 6
1992 15
1993 19
1994 13
1995 15
1996 12
1997 24
1998 16
1999 25
2000 33
2001 38
2002 46
2003 69
2004 90
2005 86
2006 79
2007 99
2008 128
2009 136
2010 142
2011 195
2012 208
2013 228
2014 262
2015 307
2016 286
2017 277
2018 326
2019 387
2020 408
2021 483
2022 513
2023 548
2024 439
2025 2

Text availability

Article attribute

Article type

Publication date

Search Results

5,331 results

Results by year

Filters applied: . Clear all
Page 1
A guide to interrogating immunometabolism.
Voss K, Hong HS, Bader JE, Sugiura A, Lyssiotis CA, Rathmell JC. Voss K, et al. Among authors: hong hs. Nat Rev Immunol. 2021 Oct;21(10):637-652. doi: 10.1038/s41577-021-00529-8. Epub 2021 Apr 15. Nat Rev Immunol. 2021. PMID: 33859379 Free PMC article. Review.
Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer.
Halbrook CJ, Pontious C, Kovalenko I, Lapienyte L, Dreyer S, Lee HJ, Thurston G, Zhang Y, Lazarus J, Sajjakulnukit P, Hong HS, Kremer DM, Nelson BS, Kemp S, Zhang L, Chang D, Biankin A, Shi J, Frankel TL, Crawford HC, Morton JP, Pasca di Magliano M, Lyssiotis CA. Halbrook CJ, et al. Among authors: hong hs. Cell Metab. 2019 Jun 4;29(6):1390-1399.e6. doi: 10.1016/j.cmet.2019.02.001. Epub 2019 Feb 28. Cell Metab. 2019. PMID: 30827862 Free PMC article.
Comparative Efficacy of Targeted Systemic Therapies for Moderate-to-Severe Atopic Dermatitis without Topical Corticosteroids: An Updated Network Meta-analysis.
Silverberg JI, Hong HC, Calimlim BM, Lee WJ, Teixeira HD, Collins EB, Crowell MM, Johnson SJ, Armstrong AW. Silverberg JI, et al. Among authors: hong hc. Dermatol Ther (Heidelb). 2023 Oct;13(10):2247-2264. doi: 10.1007/s13555-023-01000-3. Epub 2023 Sep 1. Dermatol Ther (Heidelb). 2023. PMID: 37658223 Free PMC article.
OXPHOS promotes apoptotic resistance and cellular persistence in TH17 cells in the periphery and tumor microenvironment.
Hong HS, Mbah NE, Shan M, Loesel K, Lin L, Sajjakulnukit P, Correa LO, Andren A, Lin J, Hayashi A, Magnuson B, Chen J, Li Z, Xie Y, Zhang L, Goldstein DR, Carty SA, Lei YL, Opipari AW, Argüello RJ, Kryczek I, Kamada N, Zou W, Franchi L, Lyssiotis CA. Hong HS, et al. Sci Immunol. 2022 Nov 25;7(77):eabm8182. doi: 10.1126/sciimmunol.abm8182. Epub 2022 Nov 18. Sci Immunol. 2022. PMID: 36399539 Free PMC article.
Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-label, assessor-blinded phase IV study (IMMpulse).
Stein Gold LF, Bagel J, Tyring SK, Hong HC, Pavlovsky L, Vender R, Pinter A, Reich A, Drogaris L, Wu T, Patel M, Soliman AM, Photowala H, Stakias V, Richter S, Papp KA. Stein Gold LF, et al. Among authors: hong hc. Br J Dermatol. 2023 Oct 25;189(5):540-552. doi: 10.1093/bjd/ljad252. Br J Dermatol. 2023. PMID: 37488811 Clinical Trial.
5,331 results